Abdelrady AM, Zaitone SA, Farag NE, Fawzy MS, Moustafa YM (2017) Cardiotoxic effect of levofloxacin and ciprofloxacin in rats with/without acute myocardial infarction: impact on cardiac rhythm and cardiac expression of Kv4.3, Kv1.2 and Nav1.5 channels. Biomed Pharmacother 92:196–206
Article CAS PubMed Google Scholar
Aksentijević D, Lewis HR, Shattock MJ (2016) Is rate-pressure product of any use in the isolated rat heart? Assessing cardiac ‘effort’ and oxygen consumption in the Langendorff-perfused heart. Exp Physiol 101:282–294
Antman EM (2002) Decision making with cardiac troponin tests. N Engl J Med 346:2079–2082
Aspromonte N, Monitillo F, Puzzovivo A, Valle R, Caldarola P, Iacoviello M (2014) Modulation of cardiac cytochrome P450 in patients with heart failure. Expert Opin Drug Metab Toxicol 10:327–339
Article CAS PubMed Google Scholar
Bielack SS, Erttmann R, Winkler K, Landbeck G (1989) Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacy. Eur J Cancer Clin Oncol 25:873–882
Article CAS PubMed Google Scholar
Boucek RJ Jr, Dodd DA, Atkinson JB, Oquist N, Olson RD (1997) Contractile failure in chronic doxorubicin-induced cardiomyopathy. J Mol Cell Cardiol 29:2631–2640
Article CAS PubMed Google Scholar
Bozcali E, Dedeoglu DB, Karpuz V, Suzer O, Karpuz H (2012) Cardioprotective effects of zofenopril, enalapril and valsartan against ischaemia/reperfusion injury as well as doxorubicin cardiotoxicity. Acta Cardiol 67:87–96
Buja LM, Ferrans VJ, Mayer RJ, Roberts WC, Henderson ES (1973) Cardiac ultrastructural changes induced by daunorubicin therapy. Cancer 32:771–788
Article CAS PubMed Google Scholar
Bupha-Intr T, Wattanapermpool J, Peña JR, Wolska BM, Solaro RJ (2007) Myofilament response to Ca2+ and Na+/H+ exchanger activity in sex hormone-related protection of cardiac myocytes from deactivation in hypercapnic acidosis. Am J Physiol Regul Integr Comp Physiol 292:R837-843
Article CAS PubMed Google Scholar
Callies F, Strömer H, Schwinger RH, Bölck B, Hu K, Frantz S, Leupold A, Beer S, Allolio B, Bonz AW (2003) Administration of testosterone is associated with a reduced susceptibility to myocardial ischemia. Endocrinology 144:4478–4483
Article CAS PubMed Google Scholar
Chakouri N, Farah C, Matecki S, Amedro P, Vincenti M, Saumet L, Vergely L, Sirvent N, Lacampagne A, Cazorla O (2020) Screening for in-vivo regional contractile defaults to predict the delayed doxorubicin cardiotoxicity in juvenile rat. Theranostics 10:8130–8142
Article CAS PubMed PubMed Central Google Scholar
Chan S, Friedrichs K, Noel D, Pintér T, Van Belle S, Vorobiof D, Duarte R, Gil Gil M, Bodrogi I, Murray E, Yelle L, von Minckwitz G, Korec S, Simmonds P, Buzzi F, González Mancha R, Richardson G, Walpole E, Ronzoni M, Murawsky M, Alakl M, Riva A, Crown J (1999) Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol 17:2341–2354
Article CAS PubMed Google Scholar
Chatterjee K, Zhang J, Honbo N, Karliner JS (2010) Doxorubicin cardiomyopathy. Cardiology 115:155–162
Article CAS PubMed Google Scholar
Chaudhary KR, Batchu SN, Seubert JM (2009) Cytochrome P450 enzymes and the heart. IUBMB Life 61:954–960
Article CAS PubMed Google Scholar
Choudhary D, Jansson I, Schenkman JB, Sarfarazi M, Stoilov I (2003) Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 414:91–100
Article CAS PubMed Google Scholar
Crawford J, Dale DC, Lyman GH (2004) Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 100:228–237
Cresta S, Grasselli G, Mansutti M, Martoni A, Lelli G, Capri G, Buzzi F, Cuna GR, Jirillo A, Terzoli E, Frevola L, Tarenzi E, Sguotti C, Azli N, Murawsky M, Gianni L (2004) A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer. Ann Oncol 15:433–439
Article CAS PubMed Google Scholar
Danesi R, Fogli S, Gennari A, Conte P, Del Tacca M (2002) Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs. Clin Pharmacokinet 41:431–444
Article CAS PubMed Google Scholar
de Nigris F, Rienzo M, Schiano C, Fiorito C, Casamassimi A, Napoli C (2008) Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart. Eur J Cancer 44:334–340
Elbekai RH, El-Kadi AO (2006) Cytochrome P450 enzymes: central players in cardiovascular health and disease. Pharmacol Ther 112:564–587
Article CAS PubMed Google Scholar
Elias Adikwu NB (2012) Ciprofloxacin cardiotoxicity and hepatotoxicity in humans and animals. Pharmacology and Pharmacy 3:207–2013
Engwall MJ, Everds N, Turk JR, Vargas HM (2021) The effects of repeat-dose doxorubicin on cardiovascular functional endpoints and biomarkers in the telemetry-equipped cynomolgus monkey. Front Cardiovasc Med 8:587149
Article CAS PubMed PubMed Central Google Scholar
Erdoğmuş Özgen Z, Erdinç M, Akkoç H, Kelle İ (2016) Protective effects of melatonin on doxorubicin induced cardiotoxicity in isolated rat heart. Eastern J Med 21:119–124
Eyileten C, Fitas A, Jakubik D, Czajka P, Mróz A, Czajkowska A, Witek K, Bakalarski W, De Rosa S, Postuła M, Małek ŁA (2021) Alterations in circulating microRNAs and the relation of microRNAs to maximal oxygen consumption and intima-media thickness in ultra-marathon runners. Int J Environ Res Public Health 18
Eyileten C, Wicik Z, Fitas A, Marszalek M, Simon JE, De Rosa S, Wiecha S, Palatini J, Postula M, Malek LA (2022) Altered circulating MicroRNA profiles after endurance training: a cohort study of ultramarathon runners. Front. Physiol 12:792931. https://doi.org/10.3389/fphys.2021.792931
Fisher PW, Salloum F, Das A, Hyder H, Kukreja RC (2005) Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation 111:1601–1610
Article CAS PubMed Google Scholar
Gharanei M, Hussain A, Janneh O, Maddock HL (2013) Doxorubicin induced myocardial injury is exacerbated following ischaemic stress via opening of the mitochondrial permeability transition pore. Toxicol Appl Pharmacol 268:149–156
Article CAS PubMed Google Scholar
Granfors MT, Backman JT, Neuvonen M, Neuvonen PJ (2004) Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism. Clin Pharmacol Ther 76:598–606
Article CAS PubMed Google Scholar
Gross GJ, Falck JR, Gross ER, Isbell M, Moore J, Nithipatikom K (2005) Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. Cardiovasc Res 68:18–25
Article CAS PubMed Google Scholar
Hewitt NJ, Lecluyse EL, Ferguson SS (2007) Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations. Xenobiotica 37:1196–1224
Article CAS PubMed Google Scholar
Hole LD, Larsen TH, Fossan KO, Limé F, Schjøtt J (2013) A short-time model to study relevant indices of cardiotoxicity of doxorubicin in the rat. Toxicol Mech Methods 23:412–418
Article CAS PubMed Google Scholar
Hole LD, Larsen TH, Fossan KO, Limé F, Schjøtt J (2014) Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat. BMC Pharmacol Toxicol 15:28
Article PubMed PubMed Central Google Scholar
Ikeya K, Jaiswal AK, Owens RA, Jones JE, Nebert DW, Kimura S (1989) Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression. Mol Endocrinol 3:1399–1408
Article CAS PubMed Google Scholar
Ito H, Miller SC, Billingham ME, Akimoto H, Torti SV, Wade R, Gahlmann R, Lyons G, Kedes L, Torti FM (1990) Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci U S A 87:4275–4279
Article CAS PubMed PubMed Central Google Scholar
Karkhanis A, Tram NDT, Chan ECY (2017) Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids. Biochem Pharmacol 146:188–198
Article CAS PubMed Google Scholar
Kasichayanula S, Boulton DW, Luo WL, Rodrigues AD, Yang Z, Goodenough A, Lee M, Jemal M, LaCreta F (2014) Validation of 4β-hydroxycholesterol and evaluation of other endogenous biomarkers for the assessment of CYP3A activity in healthy subjects. Br J Clin Pharmacol 78:1122–1134
Article CAS PubMed PubMed Central Google Scholar
Kirita S, Matsubara T (1993) cDNA cloning and characterization of a novel member of steroid-induced cytochrome P450 3A in rats. Arch Biochem Biophys 307:253–258
留言 (0)